Australia markets closed

GSK Jan 2025 45.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
5.00000.0000 (0.00%)
As of 02:13PM EDT. Market open.
Full screen
Previous close5.0000
Open5.0000
Bid0.0000
Ask0.0000
Strike45.00
Expiry date2025-01-17
Day's range5.0000 - 5.0000
Contract rangeN/A
Volume1
Open interestN/A
  • Insider Monkey

    10 Best Weight Loss Drug Stocks to Buy Now

    In this piece, we will take a look at the ten best weight loss drug stocks to buy now. If you want to skip our introduction to the rising weight loss drug industry and how it’s one of the biggest trends on the stock market right now, then you can take a look at the […]

  • Zacks

    GSK PLC Sponsored ADR (GSK) is Attracting Investor Attention: Here is What You Should Know

    Recently, Zacks.com users have been paying close attention to Glaxo (GSK). This makes it worthwhile to examine what the stock has in store.

  • Reuters

    UPDATE 1-U.S. FDA approves Akebia's anemia drug

    The U.S. Food and Drug Administration approved Akebia Therapeutics' drug, vadadustat, to treat anemia caused by chronic kidney disease (CKD) in dialysis patients, the drugmaker said on Wednesday. The FDA had earlier declined to approve vadadustat - a Hypoxia-inducible factor–prolyl hydroxylase (HIF-PH) inhibitor - on safety concerns, as it posed an increased risk of blood clot formations and drug-induced injuries to the liver.